The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBOTT LABS | COM | 002824100 | 4,280 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| ABBVIE INC | COM | 00287Y109 | 4,836 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| ABLYNX NV | SPONSORED ADR | 00372Y105 | 1,617 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
| ACHAOGEN INC | COM | 004449104 | 806 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| ADMA BIOLOGICS INC | COM | 000899104 | 1,926 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 700 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| AERIE PHARMACEUTICALS INC | COM | 00771V108 | 5,079 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
| AKCEA THERAPEUTICS INC | COM | 00972L107 | 1,736 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| ALLERGAN PLC | SHS | G0177J108 | 1,636 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| ANAPTYSBIO INC | COM | 032724106 | 4,029 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
| ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 1,699 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| AVEXIS INC | COM | 05366U100 | 1,660 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
| BIOGEN INC | COM | 09062X103 | 7,009 | 22,000 | SH | SOLE | 22,000 | 0 | 0 | ||
| BOSTON SCIENTIFIC CORP | COM | 101137107 | 1,240 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| BRISTOL MYERS SQUIBB CO | COM | 110122108 | 3,064 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| CATALENT INC | COM | 148806102 | 1,232 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| CELGENE CORP | COM | 151020104 | 7,827 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| CHEMOCENTRYX INC | COM | 16383L106 | 595 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| CIGNA CORPORATION | COM | 125509109 | 5,077 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | COM | 189464100 | 4,080 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | CALL | 189464900 | 1,700 | 25,000 | SH | Call | SOLE | 25,000 | 0 | 0 | |
| CORIUM INTL INC | COM | 21887L107 | 865 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
| CYTOMX THERAPEUTICS INC | COM | 23284F105 | 1,583 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| DANAHER CORP DEL | COM | 235851102 | 2,321 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
| DERMIRA INC | COM | 24983L104 | 2,781 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| DIPLOMAT PHARMACY INC | COM | 25456K101 | 1,004 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 10,864 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | ||
| GLAXOSMITHKLINE PLC | SPONSORED ADR | 37733W105 | 1,064 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 4,919 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| HUMANA INC | COM | 444859102 | 5,582 | 22,500 | SH | SOLE | 22,500 | 0 | 0 | ||
| IMMUNOMEDICS INC | COM | 452907108 | 7,272 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
| INCYTE CORP | COM | 45337C102 | 947 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| INTERSECT ENT INC | COM | 46071F103 | 2,430 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| IONIS PHARMACEUTICALS INC | COM | 462222100 | 2,012 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
| JUNO THERAPEUTICS INC | COM | 48205A109 | 2,743 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
| K2M GROUP HLDGS INC | COM | 48273J107 | 3,150 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
| KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 2,880 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| LHC GROUP INC | COM | 50187A107 | 919 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
| MARINUS PHARMACEUTICALS INC | COM | 56854Q101 | 816 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| MEDICINES CO | COM | 584688105 | 1,640 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
| MERCK & CO INC | COM | 58933Y105 | 4,502 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | 1,940 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| MYLAN N V | SHS EURO | N59465109 | 1,692 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
| MYOKARDIA INC | COM | 62857M105 | 2,105 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| NEWLINK GENETICS CORP | CALL | 651511907 | 406 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
| ONCOMED PHARMACEUTICALS INC | COM | 68234X102 | 615 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| PFIZER INC | COM | 717081103 | 1,811 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 1,730 | 17,500 | SH | SOLE | 17,500 | 0 | 0 | ||
| REGENXBIO INC | COM | 75901B107 | 998 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| SANGAMO THERAPEUTICS INC | COM | 800677106 | 2,460 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| SCYNEXIS INC | COM | 811292101 | 580 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| SIERRA ONCOLOGY INC | COM | 82640U107 | 2,984 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
| SUPERNUS PHARMACEUTICALS INC | COM | 868459108 | 1,993 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| TESARO INC | COM | 881569107 | 2,900 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
| TRANSENTERIX INC | COM NEW | 89366M201 | 241 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 2,319 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| VIKING THERAPEUTICS INC | COM | 92686J106 | 913 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
| VOYAGER THERAPEUTICS INC | COM | 92915B106 | 830 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 1,755 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| WRIGHT MED GROUP N V | ORD SHS 0.03 PAR | N96617118 | 444 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
| ZIMMER BIOMET HLDGS INC | COM | 98956P102 | 2,715 | 22,500 | SH | SOLE | 22,500 | 0 | 0 | ||